First National Advisers LLC Decreases Position in Humana Inc. (NYSE:HUM)

First National Advisers LLC reduced its holdings in Humana Inc. (NYSE:HUM - Free Report) by 27.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,715 shares of the insurance provider's stock after selling 1,048 shares during the period. First National Advisers LLC's holdings in Humana were worth $689,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. FPC Investment Advisory Inc. acquired a new stake in Humana in the 4th quarter valued at $27,000. Centricity Wealth Management LLC acquired a new stake in shares of Humana in the fourth quarter valued at about $30,000. LFA Lugano Financial Advisors SA grew its position in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares during the period. OFI Invest Asset Management acquired a new position in shares of Humana during the 4th quarter worth about $33,000. Finally, Atwood & Palmer Inc. raised its position in shares of Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after purchasing an additional 60 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have commented on HUM. Royal Bank of Canada reiterated an "outperform" rating and set a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Truist Financial boosted their price target on Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research report on Monday, January 6th. Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 12th. Barclays upped their target price on shares of Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a report on Thursday, February 13th. Finally, StockNews.com downgraded shares of Humana from a "buy" rating to a "hold" rating in a research note on Tuesday. Nineteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $285.68.

Remove Ads

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.37% of the stock is owned by insiders.

Humana Trading Down 0.3 %

Shares of NYSE HUM traded down $0.72 during mid-day trading on Thursday, reaching $266.62. 1,069,903 shares of the company's stock were exchanged, compared to its average volume of 1,624,557. The company's 50-day moving average is $271.43 and its 200-day moving average is $278.21. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a market capitalization of $32.18 billion, a price-to-earnings ratio of 26.80, a PEG ratio of 2.05 and a beta of 0.57. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana's payout ratio is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.